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Neurons and endocrine cells secrete neurotransmitters and hormones as a 
method for cell-to-cell communication through the process of exocytosis. Disruption of 
exocytosis underlie neurological disorders such as Parkinson’s disease and the 
accounts for the toxicity of clostridial neurotoxins. In order to study the regulation of 
exocytosis it is important to carry out studies at the level of single-cells and resolve 
single-vesicle release events. Carbon-fiber microelectrodes are commonly used to 
perform single-cell measurements but are slow and labor-intensive to use.  Therefore 
we are developing microchip devices with arrays of electrochemical electrodes for high-
throughput measurement of single-vesicle release events. 
One challenge in the development of these devices is automatically targeting 
individual cells to each recording electrode. Here we describe a microchip device that 
uses a self-aligning surface chemistry approach to target individual cells to each 
electrochemical microelectrode in an array. The microelectrodes are small and 
“cytophilic” in order to promote adhesion of a single cell whereas all other areas of the 
chip are covered with a thin “cytophobic” film to block cell attachement and facilitate 
movement of cells to electrodes. This cytophobic film also insulates unused areas of the 
conductive film. Amperometric spikes resulting from single-granule fusion events were 
recorded on the device and had amplitudes and kinetics similar to those measured 
using carbon-fiber microelectrodes. 
Use of this device will increase the pace of basic neuroscience research and may 
also find applications in assaying neurotoxins and development of pharmaceuticals.  
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